Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa
Rhodopsin-related dominant retinitis pigmentosa is a degenerative disease of the retina of the eye for which there is no current treatment. In this study, the authors use a novel form of RNA-interference- artificial mirtrons- to slow retinal degeneration in a mouse model of the disease.
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f079a2227d8741e1858d4c8fe8a57b28 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f079a2227d8741e1858d4c8fe8a57b28 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f079a2227d8741e1858d4c8fe8a57b282021-12-02T18:01:12ZMirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa10.1038/s41467-021-25204-32041-1723https://doaj.org/article/f079a2227d8741e1858d4c8fe8a57b282021-08-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-25204-3https://doaj.org/toc/2041-1723Rhodopsin-related dominant retinitis pigmentosa is a degenerative disease of the retina of the eye for which there is no current treatment. In this study, the authors use a novel form of RNA-interference- artificial mirtrons- to slow retinal degeneration in a mouse model of the disease.Harry O. OrlansMichelle E. McClementsAlun R. BarnardCristina Martinez-Fernandez de la CamaraRobert E. MacLarenNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-13 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Harry O. Orlans Michelle E. McClements Alun R. Barnard Cristina Martinez-Fernandez de la Camara Robert E. MacLaren Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa |
description |
Rhodopsin-related dominant retinitis pigmentosa is a degenerative disease of the retina of the eye for which there is no current treatment. In this study, the authors use a novel form of RNA-interference- artificial mirtrons- to slow retinal degeneration in a mouse model of the disease. |
format |
article |
author |
Harry O. Orlans Michelle E. McClements Alun R. Barnard Cristina Martinez-Fernandez de la Camara Robert E. MacLaren |
author_facet |
Harry O. Orlans Michelle E. McClements Alun R. Barnard Cristina Martinez-Fernandez de la Camara Robert E. MacLaren |
author_sort |
Harry O. Orlans |
title |
Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa |
title_short |
Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa |
title_full |
Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa |
title_fullStr |
Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa |
title_full_unstemmed |
Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa |
title_sort |
mirtron-mediated rna knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/f079a2227d8741e1858d4c8fe8a57b28 |
work_keys_str_mv |
AT harryoorlans mirtronmediatedrnaknockdownreplacementtherapyforthetreatmentofdominantretinitispigmentosa AT michelleemcclements mirtronmediatedrnaknockdownreplacementtherapyforthetreatmentofdominantretinitispigmentosa AT alunrbarnard mirtronmediatedrnaknockdownreplacementtherapyforthetreatmentofdominantretinitispigmentosa AT cristinamartinezfernandezdelacamara mirtronmediatedrnaknockdownreplacementtherapyforthetreatmentofdominantretinitispigmentosa AT robertemaclaren mirtronmediatedrnaknockdownreplacementtherapyforthetreatmentofdominantretinitispigmentosa |
_version_ |
1718379023467282432 |